Fast food giant McDonald’s on Monday announced it was launching a new plant-based burger named the “McPlant” to cater to the growing number of people who do not eat meat.
The brand had fallen behind in the niche market to rival Burger King, which was the first to launch a vegetarian version of its iconic “Whopper” burger in April 2019 in the United States.
Other chains like Dunkin’ or Starbucks have also dipped their toes in the growing plant-based market, as consumers become more aware their health, the impact of livestock farming on the environment and animal rights.
McDonald’s had already tested out a plant-based burger in Canada in cooperation with the company Beyond Meat, which specializes in vegan meat substitutes.
Such substitutes, like soya, have existed for a long time but new companies like Beyond Meat and Impossible Burger have developed products that closer resemble meat in taste, texture and color.
The new line will be produced exclusively for McDonald’s, and will be introduced in selected markets next year.
The restaurant chain has not yet said if it will renew its collaboration with Beyond Meat, only saying it will reach out to third-party suppliers as with all its other products.
Beyond Meat shares dropped around four percent on the announcement by the food giant.
McDonald’s told investors it was also considering plant-based substitutes for chicken products and for its egg and bacon breakfast sandwiches.
“We are excited about the opportunity because we believe we have a proven, delicious-tasting product,” said Ian Borden, who heads McDonald’s international operations.
Classics still on menu
McDonald’s still relies on its flagship products like the “Big Mac”, “McNuggets” and French fries, which account for around 70 percent of its sales in its main markets.
“As demand for the familiar in these uncertain times is more important than ever, the Company believes these core classics will continue to be significant drivers of growth thanks to both their popularity and profitability,” McDonald’s said in a statement.
The company also aims to put a new emphasis on chicken-based products, which are growing faster than the market for beef products.
Following the success of its spicy nuggets in the United States, McDonald’s plans to launch a crispy chicken sandwich there in 2021.
To boost internet sales, which have already grown significantly since the start of the coronavirus pandemic, the group will also test a new online platform and a new loyalty program.
It will also build new drive-in only outlets and have lines dedicated to customers who pre-ordered their meals online.
The group saw its global turnover fall by two percent in the third quarter due to the coronavirus pandemic.
That was nonetheless better than the 30 percent drop in sales in the second quarter, and the company managed to generate a net profit up 10 percent at $1.76 billion.
Almost all of the chain’s restaurants remained open during the pandemic.
McDonald’s to test veggie burger in Canada
© 2020 AFP
McDonald’s launching meatless ‘McPlant’ burger (2020, November 10)
retrieved 10 November 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022